India Patent Office Dismisses Compulsory License Application of Lee Pharma - (21 Jan 2016)
Indian Patent Office has dismissed application of Lee Pharma for a compulsory licence to make a copy of AstraZeneca's antidiabetes drug saxagliptin, which is branded Onglyza.
Tags : INDIAN PATENT OFFICE LEE PHARMA
Share :
|